# OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study

> **NCT07419802** · — · RECRUITING · sponsor: **Pauls Stradins Clinical University Hospital** · enrollment: 29 (estimated)

## Conditions studied

- Sepsis
- Septic Shock
- Blood Purification
- Hemoadsorption

## Interventions

- **DEVICE:** AN69-polyethylenimine hemofilter (Oxiris®) used for continuous veno-venous hemofiltration (CVVH)

## Key facts

- **NCT ID:** NCT07419802
- **Lead sponsor:** Pauls Stradins Clinical University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2027-09-01
- **Final completion:** 2027-09-01
- **Target enrollment:** 29 (ESTIMATED)
- **Last updated:** 2026-02-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07419802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07419802, "OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07419802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*